Anti-SARS-CoV-2 Spike Antibody Response to Seven Doses of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Hemodialysis Patients
Background: We evaluated the anti-SARS-CoV-2 spike antibody response following seven doses of the BNT162b2 messenger RNA COVID-19 vaccine in patients undergoing hemodialysis and investigated factors associated with antibody levels after the fifth, sixth, and seventh doses. Methods: Forty patients were recruited in the...